We administered recombinant human erythropoietin to 25 anemic patients with end-stage
renal disease who were undergoing hemodialysis. The recombinant human erythropoietin …

Background A program for banking, characterizing, and distributing placental blood, also
called umbilical-cord blood, for transplantation provided grafts for 562 patients between August …

Study Objective: To determine the effectiveness and safety of recombinant human
erythropoietin (rHuEpo). Patients: Hemodialysis patients (333) with uncomplicated anemia (hematocrit …

Clinical evidence of hematopoietic restoration with placental/umbilical cord blood (PCB)
grafts indicates that PCB can be a useful source of hematopoietic stem cells for routine bone …

Two women with polycythemia vera and heterozygosity (Gd B /Gd A ) at the X-chromosomelinked
locus for glucose-6-phosphate dehydrogenase were studied to determine the nature of …

Although advances have been made in understanding cell differentiation, only rudimentary
knowledge exists concerning how differentiated cells form tissues and organs. We studied …

To examine the effects of erythropoietin on the anemia of chronic renal disease and on the
rate of renal deterioration, we administered recombinant human erythropoietin to 17 patients …

Mechanisms of thrombocytopenia were studied in 38 patients with mild to moderately severe
chronic autoimmune thrombocytopenia (AITP). 51Cr and 111In-labeled autologous platelet …

Bone marrow transplantation (BMT) is indicated for selected genetic and hematologic diseases
and for hematopoietic reconstitution in cases of iatrogenic or accidental ablation of BM.’-…

It is estimated that one‐third of the world's population is anemic, the majority being due to
iron deficiency (ID). In adults, ID is associated with fatigue in the absence of anemia, restless …